Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
OptiBiotix Health PLC (OPTI:LON) | 10.8 0 0.0% | Mkt Cap: 11.1m
Cavendish Research
3 pages
OptiBiotix (OPTI): Corp European licence agreement for LP-LDL
Companies: CGS REC CMET FDEV TENG OPTI WPHO CREO VRCI
Companies: BKYTLWRCHREDOPTIMTFB5EQHCM
Companies: DPP WINK PYC EMAN IXI JNEO OPTI G4M CRTA
Companies: SYGGFPRMHEADIOMAGYEMRTSTLCTHPHDCNSLVANQSDIBVXPINSECOGFDEVYGENABZAEPWNOPTISPEMTFBIHCAVCTLDRUFDVLWX1
Companies: TRCS PHAR OPTI IHC DUKE HE1 SVML FRG OBI
